Catecholamines and attention. I: Animal and clinical studies

Area of Science:

• Neuroscience
• Cognitive Science

Background:

• Catecholamine neurotransmitters, specifically dopamine and noradrenaline, are implicated in the cerebral cortex's attentional functions.
• Projections from the reticular formation, including midbrain dopamine neurons and pontine noradrenergic neurons, are of significant interest.

Purpose of the Study:

• To review the roles of noradrenaline and dopamine in attention-related behaviors.
• To explore the association between catecholamine activity and attentional dysfunction in human clinical conditions.
• To elucidate the specific roles of dopamine and noradrenaline in information processing stages.

Main Methods:

• Review of animal studies on attention-related behaviors.
• Analysis of human clinical literature concerning schizophrenia, Parkinson's disease, and attention deficit disorder.
• Examination of the impact of central dopamine pathway lesions on response selection.

Main Results:

• Animal studies link noradrenaline and dopamine to various attention behaviors like search, distractibility, and attentional switching.
• Human studies associate attentional deficits in schizophrenia, Parkinson's disease, and ADHD with abnormal catecholamine activity, particularly dopamine.
• Dopamine appears critical for appropriate response selection to environmental stimuli.

Conclusions:

• Central noradrenaline and dopamine are vital for attention.
• Noradrenaline and dopamine are involved in early and late information processing, respectively.
• Dysfunctional catecholamine systems contribute to attentional deficits observed in neurological and psychiatric disorders.